Equifax Inc
9 nominees · 5 ballot items.
Elect ten directors; advisory vote on executive compensation (“say-on-pay”); ratify Ernst & Young LLP as auditor; advisory vote to lower special meeting ownership threshold to 25% (management); shareholder proposal to lower special meeting ownership threshold to 10% (shareholder).
Follow how the vote landed and what changed on Equifax Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot5
- 1
Election of Ten Directors
ManagementBoard: FORElect the ten director nominees named in the proxy statement to serve until the next annual meeting.
- 2
Advisory Vote to Approve Named Executive Officer Compensation (Say-on-Pay
ManagementBoard: FORNon-binding advisory vote to approve the compensation of the Company’s named executive officers as disclosed in the proxy statement.
More detail
The proposal asks shareholders to cast a non-binding advisory vote approving the Company’s executive compensation disclosure and practices (say-on-pay). Management seeks shareholder support to validate its compensation philosophy that heavily weights long-term performance-based incentives tied to TSR and Adjusted EBITDA, and to confirm alignment between pay and company strategy, including EFX.AI deployment and cloud transition. The board recommends a vote FOR, arguing the compensation structure incentivizes long-term value creation, includes robust governance features (clawbacks, stock ownership requirements, independent consultant review), and has substantial shareholder support previously (92% in 2025). Important context includes recent increases in CEO LTI to retain leadership and changes to LTI design for 2026 to emphasize Adjusted EBITDA with TSR modifier and extended holding periods; management argues these changes respond to shareholder feedback while maintaining pay-for-performance alignment. Opponents might point to higher realized CEO pay in certain years and the increased LTI grant in 2025; the board counters with CEO deferral elections and enhanced retention features tied to longer timelines. The vote is advisory but board will consider results in future compensation decisions.
- 3
Ratification of Appointment of Ernst & Young LLP as Independent Registered Public Accounting Firm for 2026
ManagementBoard: FORRatify the Audit Committee’s appointment of Ernst & Young LLP as independent auditor for 2026.
- 4
Advisory Vote to Lower Ownership Threshold to Call a Special Meeting of Shareholders to 25%
ManagementBoard: FORNon-binding advisory proposal by management to amend the Bylaws to allow shareholders holding at least 25% of outstanding common stock (held continuously for at least one year) to request a special meeting.
- 5
Shareholder Proposal to Lower Ownership Threshold to Call a Special Meeting of Shareholders to 10%
Shareholder — John CheveddenBoard: AGAINSTShareholder-submitted proposal requesting the Company to amend governing documents to permit shareholders owning 10% of outstanding common stock to call a special meeting.
Nominees on the ballot9
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 6.6% | 7,825,105 | $1.4B |
| 2 | HARRIS ASSOCIATES L P | 6.2% | 7,353,105 | $1.3B |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4.4% | 5,271,004 | $949M |
| 4 | STATE STREET CORP | 4.2% | 5,023,592 | $905M |
| 5 | Soroban Capital Partners LP | 3.5% | 4,184,569 | $754M |
| 6 | Capital International Investors | 3.1% | 3,676,942 | $662M |
| 7 | BlackRock, Inc. | 3.1% | 3,656,104 | $658M |
| 8 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 3.0% | 3,541,308 | $638M |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 2.4% | 2,812,162 | $504M |
| 10 | BlackRock, Inc. | 2.1% | 2,499,760 | $450M |
Other Industrials sector meetings6
Upcoming shareholder meetings at Equifax Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Equifax Inc 2026 annual meeting?
- Equifax Inc (EFX) holds its 2026 annual shareholder meeting on Thursday, May 7, 2026.
- What is the record date for the Equifax Inc 2026 meeting?
- The record date for the Equifax Inc 2026 meeting is Monday, March 9, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Equifax Inc's 2026 meeting?
- The board is presenting 9 director nominees at the Equifax Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Equifax Inc 2026 meeting?
- Shareholders will vote on 5 proposals at the Equifax Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.